Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions
Molecules · 16.02.2023 · 28 (4) · 1874
DOI: 10.3390/molecules28041874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 16.02.2023. Verfasst von Cunsi Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Berberine, Metabolic Diseases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Featured innovation projects (undergraduate) of ordinary universities in Guangdong Province, Guangdong University Characteristic Innovation Project.
Abstract (Originalsprache)
Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases, which in turn triggers mild inflammation, metabolic dysfunction, fibrosis, and even cancer. Accumulating evidence has suggested that Berberine (BBR) could significantly improve MAFLD progression. Clock and Bmal1 as heterodimer proteins highly participated in the development of MAFLD, but whether BBR targets Clock and Bmal1 in MAFLD remains poorly understood. The result suggested that the protein levels of Clock and Bmal1 were decreased in MAFLD mice, which was negatively correlated with elevated reactive oxygen species (ROS) accumulation, the H2O2 level, liver inflammation, metabolic dysfunction, and insulin resistance. The mRNA and protein levels of Clock and Bmal1 were also decreased in glucosamine-induced HepG2 cells, which were are negatively related to glucose uptake, the ROS level, and the H2O2 level. More importantly, Bmal1 siRNA could mimic the effect of glucosamine in HepG2 cells. Interestingly, Berberine (BBR) could rescue metabolism disorder and redox homeostasis through enhancing Clock and Bmal1 expression in vivo and in vitro. Therefore, BBR might be an effective natural compound for alleviating redox homeostasis, metabolism disorder, and liver pathological changes in MAFLD by activating Clock and Bmal1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
ORCID-Profile: Cunsi Ye
Förderung
- Featured innovation projects (undergraduate) of ordinary universities in Guangdong Province
- Guangdong University Characteristic Innovation Project
Zitieren
APA
Ye, C., Zhang, Y., Lin, S., Chen, Y., Wang, Z., Feng, H., Fang, G., & Quan, S. (2023). Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions. Molecules, 28(4), 1874. https://doi.org/10.3390/molecules28041874
Vancouver
Ye C, Zhang Y, Lin S, Chen Y, Wang Z, Feng H, et al. Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions. Molecules. 2023;28(4):1874. doi:10.3390/molecules28041874
BibTeX
@article{Ye2023,
author = {Ye, Cunsi and Zhang, Yajing and Lin, Shaomin and Chen, Yi and Wang, Zimiao and Feng, Haoyinghua and Fang, Guangqing and Quan, Shijian},
title = {Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions},
journal = {Molecules},
year = {2023},
volume = {28},
number = {4},
pages = {1874},
doi = {10.3390/molecules28041874}
}
EUVIMED